Department of Surgery, Division of Hepatobiliary & General Surgery, Humanitas University and Research Hospital, Rozzano-Milan, Italy.
Department of Medical and Surgical Sciences, General Surgery and Transplantation Unit, University of Bologna, Italy.
HPB (Oxford). 2019 Oct;21(10):1411-1418. doi: 10.1016/j.hpb.2019.04.001. Epub 2019 May 9.
In case of bilobar colorectal liver metastases (CLM) associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been proposed. Enhanced one-stage ultrasound-guided hepatectomy (e-OSH) may represent a further solution for these patients. Aim of this study was to compare by case-match analyses the outcome of ALPPS and e-OSH.
Between 2012 and 2017, patients undergoing ALPPS for bilobar CLM were matched 1:2 with patients receiving e-OSH. Patients were matched according to the Fong Score (1-3/4-5), the number of CLM (3-7/≥8), the number of CLM in the left liver (1-2/≥3) and preoperative chemotherapy. All the patients in the e-OSH group had a right -sided major vascular contact. The main endpoints of the study were perioperative outcomes, overall (OS) and disease-free survival (DFS).
Seventy-eight patients were selected (26 ALPPS and 52 e-OSH) based on matching process. The two treatments differed significantly in major morbidity (26.9% ALPPS vs 7.7% e-OSH, p = 0.017). Median OS (31.7 vs 32.6 months) and DFS (10.6 vs 7.8 months) were comparable between the two groups.
This study demonstrates that ALPPS and e-OSH for bilobar CLM achieve comparable long-term results, despite higher morbidity reported after ALPPS. These findings should drive to reposition e-OSH in managing these patients.
对于双侧结直肠癌肝转移(CLM)合并肝分区和门静脉结扎分期肝切除术(ALPPS)已经被提出。增强型一期超声引导肝切除术(e-OSH)可能是这些患者的进一步解决方案。本研究旨在通过病例匹配分析比较 ALPPS 和 e-OSH 的结果。
2012 年至 2017 年间,对双侧 CLM 行 ALPPS 的患者与接受 e-OSH 的患者进行 1:2 病例匹配。根据 Fong 评分(1-3/4-5)、CLM 数量(3-7/≥8)、左肝 CLM 数量(1-2/≥3)和术前化疗对患者进行匹配。e-OSH 组的所有患者均有右侧主要血管接触。本研究的主要终点是围手术期结果、总生存期(OS)和无病生存期(DFS)。
根据匹配过程,共选择了 78 例患者(26 例 ALPPS 和 52 例 e-OSH)。两种治疗方法在主要发病率方面差异显著(26.9%ALPPS 与 7.7%e-OSH,p=0.017)。两组的中位 OS(31.7 与 32.6 个月)和 DFS(10.6 与 7.8 个月)相当。
本研究表明,双侧 CLM 的 ALPPS 和 e-OSH 可获得相当的长期结果,尽管 ALPPS 后报告的发病率较高。这些发现应促使 e-OSH 在治疗这些患者时重新定位。